Oncimmune Regulatory News (ONC)

For immediate release

PDMR

Previous holding of Ordinary Shares

Number of Subscription Shares purchased

Resultant shareholding

Resulting % of Enlarged Share Capital

Alistair Macdonald

55,555

100,000

155,555

0.14

Martin Gouldstone

36,023

66,667

102,690

0.09

John Goold

1,150,000

333,333

1,483,333

1.33

PDMR

Number of options waived

Date of grant of options waived

Exercise price of options waived

Resulting number of options held

Martin Gouldstone

589,971

7 November 2023

£0.1695

0

Martin Hudson

105,263

8 December 2023

£0.266

0

PDMR

Number of options granted

Exercise price

% of Enlarged Share Capital

Martin Gouldstone

5,588,661

£0.15

5%

Martin Hudson

3,353,197

£0.15

3%

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Alistair Macdonald

1. 

Reason for the notification

a)

Position/status:

Chairman

b)

Initial notification/Amendment:

Initial notification

2. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Oncimmune Holdings plc

b)

LEI:

213800HCYIWT6YPI1I02

3. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each ("Ordinary Shares")

GB00BYQ94H38

b)

Nature of the transaction:

Purchase of new ordinary shares

c)

Price(s) and volume(s):

d)

Aggregated information:

· Aggregated volume:

· Aggregated Price:

Single transaction as in 3 c) above

e)

Date of the transaction:

23 October 2024

f)

Place of the transaction:

AIM, London Stock Exchange (XLON)

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Martin Gouldstone

1. 

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

2. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Oncimmune Holdings plc

b)

LEI:

213800HCYIWT6YPI1I02

3. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each ("Ordinary Shares")

GB00BYQ94H38

b)

Nature of the transaction:

Purchase of new ordinary shares

c)

Price(s) and volume(s):

d)

Aggregated information:

· Aggregated volume:

· Aggregated Price:

Single transaction as in 3 c) above

e)

Date of the transaction:

23 October 2024

f)

Place of the transaction:

AIM, London Stock Exchange (XLON)

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

John Goold

1. 

Reason for the notification

a)

Position/status:

Non-Executive Director

b)

Initial notification/Amendment:

Initial notification

2. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Oncimmune Holdings plc

b)

LEI:

213800HCYIWT6YPI1I02

3. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each ("Ordinary Shares")

GB00BYQ94H38

b)

Nature of the transaction:

Purchase of new ordinary shares

c)

Price(s) and volume(s):

d)

Aggregated information:

· Aggregated volume:

· Aggregated Price:

Single transaction as in 3 c) above

e)

Date of the transaction:

23 October 2024

f)

Place of the transaction:

AIM, London Stock Exchange (XLON)

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Martin Gouldstone

1. 

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

2. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Oncimmune Holdings plc

b)

LEI:

213800HCYIWT6YPI1I02

3. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each ("Ordinary Shares")

GB00BYQ94H38

b)

Nature of the transaction:

Waiver of options

c)

Price(s) and volume(s):

d)

Aggregated information:

· Aggregated volume:

· Aggregated Price:

Single transaction as in 3 c) above

e)

Date of the transaction:

8 November 2024

f)

Place of the transaction:

Outside a trading venue

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Martin Hudson

1. 

Reason for the notification

a)

Position/status:

Finance Director

b)

Initial notification/Amendment:

Initial notification

2. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Oncimmune Holdings plc

b)

LEI:

213800HCYIWT6YPI1I02

3. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each ("Ordinary Shares")

GB00BYQ94H38

b)

Nature of the transaction:

Waiver of options

c)

Price(s) and volume(s):

d)

Aggregated information:

· Aggregated volume:

· Aggregated Price:

Single transaction as in 3 c) above

e)

Date of the transaction:

8 November 2024

f)

Place of the transaction:

Outside a trading venue

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Martin Gouldstone

1. 

Reason for the notification

a)

Position/status:

Chief Executive Officer

b)

Initial notification/Amendment:

Initial notification

2. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Oncimmune Holdings plc

b)

LEI:

213800HCYIWT6YPI1I02

3. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each ("Ordinary Shares")

GB00BYQ94H38

b)

Nature of the transaction:

Grant of options

c)

Price(s) and volume(s):

d)

Aggregated information:

· Aggregated volume:

· Aggregated Price:

Single transaction as in 3 c) above

e)

Date of the transaction:

8 November 2024

f)

Place of the transaction:

Outside a trading venue

1. 

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Martin Hudson

1. 

Reason for the notification

a)

Position/status:

Finance Director

b)

Initial notification/Amendment:

Initial notification

2. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Oncimmune Holdings plc

b)

LEI:

213800HCYIWT6YPI1I02

3. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

Ordinary shares of 1 pence each ("Ordinary Shares")

GB00BYQ94H38

b)

Nature of the transaction:

Grant of options

c)

Price(s) and volume(s):

d)

Aggregated information:

· Aggregated volume:

· Aggregated Price:

Single transaction as in 3 c) above

e)

Date of the transaction:

8 November 2024

f)

Place of the transaction:

Outside a trading venue